AMC Entertainment reports narrower-than-expected Q4 loss amid box office recovery

AMC reported Q4 revenue of $1.29 billion, down 1.4% year-over-year but above consensus of $1.27 billion, and a narrower-than-expected net loss of $127.4 million ($0.18/share) versus an anticipated $0.21 loss. Q4 adjusted EBITDA fell to $134.1 million from $164.8 million a year earlier, while net cash from operations was $126.7 million and quarterly free cash flow was $43.3 million; year revenue rose to $4.85 billion but full-year net loss widened to $632.4 million largely due to non-cash charges from a July 2025 refinancing. Management highlighted record per-patron revenue, portfolio optimization and a stronger box office backdrop with positive forward-looking commentary on the 2026 film slate, while the stock traded down ~1.3% to $1.20 post-release.

Analysis

Market structure: AMC’s print signals selective winners — exhibitors with strong loyalty programs and premium F&B (AMC) and studios with reliable franchise sequels gain pricing power; budget exhibitors and streaming-first content producers are relatively disadvantaged if theatrical windows re-expand. The modest revenue beat (+$1.29B vs $1.27B est.) and record per-patron receipts suggest demand-side recovery: admissions + ancillary spend per ticket are increasing even as unit volumes remain below pre-pandemic highs, implying pricing leverage rather than supply constraints. Credit markets should reprice near-term risk lower (2026 maturities redeemed) but long-dated credit still faces FCF stress; expect elevated equity and options vol until summer blockbusters prove out demand.

Risk assessment: Tail risks include a major box-office flop cycle (studio miss across 2–3 tentpoles), acute retail-driven volatility/dilution (equity raise >$200M), or macro consumer shock reducing discretionary spending; each could halve market cap in weeks. Immediate (days) risk: volatile retail flows and headline trading; short-term (weeks/months): response to early-2026 releases and any ATM equity activity; long-term (quarters) hinges on FCF trajectory (free cash flow was -$365.9M in 2025). Hidden dependency: AMC’s narrative relies on studios delivering 3–4 tentpole hits in 2026; labor/production disruptions or shifts to streaming materially change outcomes.

Trade implications: Favor convex, limited-loss exposure to upside into the summer slate — buy-call spreads expiring Jun–Aug 2026 to capture catalysts while limiting downside. Keep outright equity exposure tiny (1–3% notional) with strict stop-loss (25% from entry) due to dilution risk and meme volatility. Avoid committing to long-dated investment-grade or high-yield AMC bonds until FCF turns positive or leverage targets fall (net debt/EBITDA <4x).

Contrarian angles: Consensus underweights operational improvements (adj. EBITDA +12.6% y/y to $387.5M) and record per-patron metrics, so a well-sequenced slate could produce outsized re-rating rather than gradual recovery. Reaction is underdone if studios deliver 2–3 breakout films — price >$3.00 becomes plausible by autumn 2026; conversely market underestimates dilution risk so negative surprises can be swift. Historical parallel: 2010s theatrical recoveries show revenue rebounds concentrated around a few tentpoles, not broad-based steady rises — binary outcomes dominate.

Key Decisions for Investors

• Establish a tactical, limited-risk bullish position: allocate 1.5–2.0% of portfolio notional to a Jun–Aug 2026 AMC (NYSE:AMC) call spread (buy $1.50 call, sell $3.00 call) to capture summer/fall tentpole upside; take profits if AMC > $2.50 or spread up +50%; cut entire position if premium drops -40% or AMC prints an equity raise >$200M.
• If comfortable with higher tail risk, establish a 1% outright long equity position in AMC at price <= $1.50 with a stop-loss at -25% and a take-profit tranche at +50% (exit half) and +150% (exit remainder) tied to positive box-office confirmations through Aug 2026.
• Execute a relative-value pair: long the AMC Jun–Aug 2026 $1.50/$3.00 call spread (0.75% notional) and short 0.75% notional of Cinemark (CNK) equity to express preference for AMC’s loyalty/premium monetization; unwind if CNK outperforms AMC by >10% over any 30-day window.
• Defer purchases of AMC corporate bonds or high-yield exposure until free cash flow turns positive or the company announces a clear deleveraging target (net debt/EBITDA <4x); monitor quarterly FCF (next report) and any ATM/equity issuance filings in the next 60 days before bond allocation.